-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$68.92290.48% Upside
NovoCure Limited Frequently Asked Questions
-
What analysts cover NovoCure Limited?
NovoCure Limited has been rated by research analysts at H.C. Wainwright, Evercore ISI, Piper Sandler, Wells Fargo, J.P. Morgan, Loop Capital Markets in the past 90 days.